Nonlinear Models of mRNA Expression in Cancer by RT-PCR
Nonlinear Models of mRNA Expression in Cancer by RT-PCR
批准号:
7673687
负责人:
Terry HYSLOP
金额:
$14.26万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-16 至 2011-08-31
关键词:
AccountingAgeAlgorithmsAreaBiological AssayBiological MarkersBloodBlood specimenCancer PatientCancerousCause of DeathCellsClinicalClinical TrialsColorectal CancerColorectal SurgeryComparative StudyComputer softwareDNA copy numberDataData AnalysesDatabasesDependenceDetectionDevelopmentDiagnosisDiscriminationDiseaseEmerging TechnologiesEnzyme-Linked Immunosorbent AssayExcisionFluorescenceFundingGenerationsGoalsGrowthHeterogeneityInstitutionInvestigationKineticsLaboratoriesLeast-Squares AnalysisLiteratureLogisticsMalignant NeoplasmsMeasurementMeasuresMessenger RNAMethodologyMethodsMicrometastasisModelingMolecularNatureNon-linear ModelsPatientsPerformancePhasePilot ProjectsPolymerase Chain ReactionPremalignantPrevention therapyPrincipal InvestigatorProceduresProcessPropertyReactionRecurrenceReverse Transcriptase Polymerase Chain ReactionReverse TranscriptionRunningSamplingSensitivity and SpecificitySourceStagingStatistical MethodsStructureTechniquesTechnologyTestingTimeTissue SampleTissuesTranscriptUnited StatesVariantWorkbasecancer celldesignenterotoxin receptorimprovedinnovationlymph nodesmRNA Expressionmortalitynovelnovel strategiesperipheral bloodprognosticprogramsresearch studysimulation
中文摘要
描述(由申请人提供):该项目的总体目标是改进定量实时聚合酶链反应(Q-RT-PCR)相关的数据分析程序,特别关注分子生物标志物mRNA表达的测量及其与结直肠癌的关系。结直肠癌是美国第三大最常见的恶性肿瘤,也是癌症相关死亡的第三大常见原因。虽然切除治疗是这些患者的主要治疗方案,但超过50%的假定治愈的患者将在三到五年内复发。据推测,这些复发实际上是未被发现的微转移。我们建议采用Q-RT-PCR技术,改变基于非线性动力学模型的定量mRNA表达量的方法。目前的定量方法并没有利用动力学RT-PCR反应的大部分数据,而且目前模型的假设与实验的现实不匹配。因此,我们还建议扩展这些模型的误差结构,以考虑样品的连续稀释、浓度的异质性和重复样本的依赖性。我们的假设是,改进分子生物标志物数量的测量将为结直肠癌患者提供更准确的预后信息。来自NCI资助的两项多中心胍基环化酶-c (GCC)试验的数据可用于这些研究,以证明我们提出的方法的临床实用性。
英文摘要
DESCRIPTION (provided by applicant): The overall goal of this project is to improve the data analytic procedures associated with quantitative real-time polymerase chain reaction (Q-RT-PCR), with particular focus on measuring mRNA expression of molecular biomarkers and their association with colorectal cancer. Colorectal cancer is the third most common malignancy in the United States, and the third most common cause of death among cancer-related mortalities. While resection therapy is the main course of treatment for these patients, over 50% of patients presumed cured will recur within three to five years. It is hypothesized that these recurrences are actually undetected micrometastases. We propose to adapt Q-RT-PCR technology by changing the methods to quantify the amount of mRNA expression based on nonlinear models of the kinetic reaction obtained from Q-RT-PCR experiments. The current approach to quantitation does not make use of most of the data from the kinetic RT-PCR reaction, and the assumptions of the current model do not match the reality of the experiments. Thus, we also propose extensions of the error structure of these models to account for serial dilution of samples, heterogeneity across concentrations, and dependence of replicate samples. It is our hypothesis that improved measurement of the quantity of molecular biomarkers will offer more accurate prognostic information for colorectal cancer patients. Data from two NCI funded multi-center trials of guanylyl-cyclase-C (GCC) are available for these studies to demonstrate the clinical utility of our proposed methods.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core 2: Biostatistics and Bioinformatics
-
批准号:10037511
-
项目类别:
-
资助金额:$12.87万
-
财政年份:2020
-
负责人:Terry HYSLOP
-
依托单位:
Core 2: Biostatistics and Bioinformatics
-
批准号:10263347
-
项目类别:
-
资助金额:$13.24万
-
财政年份:2020
-
负责人:Terry HYSLOP
-
依托单位:
Biostatistics
-
批准号:8302943
-
项目类别:
-
资助金额:$17.61万
-
财政年份:2011
-
负责人:Terry HYSLOP
-
依托单位:
Biostatistics
-
批准号:8084099
-
项目类别:
-
资助金额:$18.66万
-
财政年份:2010
-
负责人:Terry HYSLOP
-
依托单位:
Nonlinear Models of mRNA Expression in Cancer by RT-PCR
-
批准号:6861355
-
项目类别:
-
资助金额:$14.03万
-
财政年份:2005
-
负责人:Terry HYSLOP
-
依托单位:
Nonlinear Models of mRNA Expression in Cancer by RT-PCR
-
批准号:7500416
-
项目类别:
-
资助金额:$26.42万
-
财政年份:2005
-
负责人:Terry HYSLOP
-
依托单位:
Nonlinear Models of mRNA Expression in Cancer by RT-PCR
-
批准号:7501353
-
项目类别:
-
资助金额:$25.91万
-
财政年份:2005
-
负责人:Terry HYSLOP
-
依托单位:
Biostatistics
-
批准号:8378876
-
项目类别:
-
资助金额:$17.17万
-
财政年份:--
-
负责人:Terry HYSLOP
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: